Response to Drs. Bell and Moore commentary regarding the use of intravenous ketamine for CRPS
- PMID: 20813460
- DOI: 10.1016/j.pain.2010.08.018
Response to Drs. Bell and Moore commentary regarding the use of intravenous ketamine for CRPS
Comment on
-
Intravenous ketamine for CRPS: Making too much of too little?Pain. 2010 Jul;150(1):10-11. doi: 10.1016/j.pain.2010.03.014. Epub 2010 Mar 26. Pain. 2010. PMID: 20347222 No abstract available.
References
-
- Bell RF, Moore RA. Intravenous ketamine for CRPS: making too much of too little? Pain. 2010;150:10-11.
-
- Curran HV, Monaghan L. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction. 2001;96:749-760.
-
- Kiefer RT, Rohr P, Ploppa A, Dieterich HJ, Grothusen J, Koffler S, Altemeyer KH, Unertl K, Schwartzman RJ. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med. 2008;9:1173-1201.
-
- Koffler SP, Hampstead BM, Irani F, Tinker J, Kiefer RT, Rohr P, Schwartzman RJ. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol. 2007;22:719-729.
-
- Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M, Kegeles LS, Talbot PS, Huang Y, Hwang DR, Khenissi L, Cooper TB, Laruelle M, Abi-Dargham A. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry. 2005;162:2352-2359.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
